Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: SELUX DIAGNOSTICS, INC.
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2018-09-24 to 2025-05-31
Current total value of award: $62626467.91
Description: THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE FOR CLIN0006 OPTION 2C THROUGH MAY 31, 2025, AT NO ADDITIONAL COST TO THE GOVERNMENT DUE TO THE 2-MONTH DELAY IN SUBMISSION OF THE 510(K) PACKAGE TO THE FDA AND UPDATE ARTICLE I.